Prednisone Completed Phase 2 / 3 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000421Serologically Active, Clinically Stable Systemic Lupus Erythematosus